REBECCA MEUNIER: Open Payments
NPI 1841631066 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,398 in 49 payments from 18 companies in 2025. Trend: 2023 $807 · 2024 $1,191 · 2025 $1,398
Food & beverage: $1,398
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $262 |
| Sumitomo Pharma America, Inc. | 9 | $236 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $204 |
| Dendreon Pharmaceuticals LLC | 5 | $155 |
| Calyxo, Inc. | 1 | $76 |
| PFIZER INC. | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $54 |
| Teleflex LLC | 2 | $48 |
| BIOPROTECT MEDICAL, INC. | 1 | $47 |
Products named: Nubeqa, ORGOVYX, PROVENGE, ERLEADA, RYBREVANT, CVAC ASPIRATION SYSTEM, XTANDI, LYNPARZA.
Industry payments across AZ — which companies pay providers there.
